However, in a recent study, a team confirmed the presence of CTCs in ES patients based on the immunodetachment of CD99+ tumor cells and magnetic beads, followed by molecular analysis to detect specific fusion transcripts from chromosomal translocations,457 which provides a new way of detecting CTCs. The gene discussed is CD99; the disease is neoplasm.